Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-1289-2020

Drug recall · June 10, 2020

Lamotrigine Tablets recall

Why: Presence of Foreign Substance consistent with granules from desiccant packs used during storage

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Lamotrigine Tablets, USP, 150 mg, Rx Only, a) 60 count Bottle, NDC 42291-368-60, b) 500 count Bottle, NDC 42291-368-50, Manufactured for: AvKARE, Inc. Pulaski, TN 38478.

Lots / codes

Lot #: a) 25634, b) 25633; Exp. 09/30/2021

Quantity
4124 bottles
Company
AVKARE Inc., Pulaski, TN
Distribution
Nationwide in the U.S.
Initiated
May 28, 2020 · Voluntary: Firm initiated
Classified
June 4, 2020
Reported
June 10, 2020
Ended
October 22, 2021
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Lamotrigine

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.